MEK inhibitors block growth of lung tumors with mutations in Ataxia Telangiectasia Mutated
Lung cancer is the leading cause of cancer deaths, and effective treatments are urgently needed. Loss-of-function mutations in the DNA damage response kinase ATM are common in lung adenocarcinoma but directly targeting these with drugs remains challenging. Here we report that ATM loss-of-function is...
Príomhchruthaitheoirí: | Smida, M, Fece de la Cruz, F, Kerzendorfer, C, Muir, B, Konopka, T, Nijman, S |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
Nature Publishing Group
2016
|
Míreanna comhchosúla
-
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
de réir: Michal Smida, et al.
Foilsithe / Cruthaithe: (2016-12-01) -
Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
de réir: Boultwood, J
Foilsithe / Cruthaithe: (2001) -
Association of Ataxia Telangiectasia Mutated (ATM) gene mutation/deletion with Rhabdomyosarcoma
de réir: Feramisco James R, et al.
Foilsithe / Cruthaithe: (2003-01-01) -
The role of the ataxia telangiectasia mutated gene in lung cancer: recent advances in research
de réir: Yanling Xu, et al.
Foilsithe / Cruthaithe: (2017-09-01) -
Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer
de réir: Weber, A, et al.
Foilsithe / Cruthaithe: (2016)